Correlation Between Aerovate Therapeutics and Qrons

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Qrons at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Qrons into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Qrons Inc, you can compare the effects of market volatilities on Aerovate Therapeutics and Qrons and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Qrons. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Qrons.

Diversification Opportunities for Aerovate Therapeutics and Qrons

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aerovate and Qrons is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Qrons Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qrons Inc and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Qrons. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qrons Inc has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Qrons go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Qrons

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Qrons. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 1.18 times less risky than Qrons. The stock trades about -0.04 of its potential returns per unit of risk. The Qrons Inc is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  16.00  in Qrons Inc on September 13, 2024 and sell it today you would earn a total of  2.00  from holding Qrons Inc or generate 12.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Qrons Inc

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Qrons Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Qrons Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Qrons is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Aerovate Therapeutics and Qrons Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Qrons

The main advantage of trading using opposite Aerovate Therapeutics and Qrons positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Qrons can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qrons will offset losses from the drop in Qrons' long position.
The idea behind Aerovate Therapeutics and Qrons Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios